BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33302956)

  • 1. Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes.
    Oga-Omenka C; Bada F; Agbaje A; Dakum P; Menzies D; Zarowsky C
    Int J Equity Health; 2020 Dec; 19(1):221. PubMed ID: 33302956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the gaps in DR-TB care cascade in Nigeria: A sequential mixed-method study.
    Oga-Omenka C; Boffa J; Kuye J; Dakum P; Menzies D; Zarowsky C
    J Clin Tuberc Other Mycobact Dis; 2020 Dec; 21():100193. PubMed ID: 33102811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
    Bieh KL; Weigel R; Smith H
    BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to free or low-cost tuberculosis treatment for migrants and refugees along the Thailand-Myanmar border in Tak province, Thailand.
    Tschirhart N; Nosten F; Foster AM
    Int J Equity Health; 2016 Jul; 15(1):100. PubMed ID: 27388710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study.
    Vanleeuw L; Atkins S; Zembe-Mkabile W; Loveday M
    BMJ Open; 2020 Feb; 10(2):e032591. PubMed ID: 32019816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pragmatic Management of Drug-Resistant Tuberculosis: A Qualitative Analysis of Human Resource Constraints in a Resource-Limited Country context-Ethiopia.
    Mussie KM; Gradmann C; Yimer SA; Manyazewal T
    Int J Public Health; 2021; 66():633917. PubMed ID: 34434083
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors contributing to drug-resistant tuberculosis treatment outcome in five countries in the Eastern Europe and Central Asia region.
    Auer C; Mazitov R; Makhmudov A; Pirmahmadzoda B; Skrahina A; Dobre A; Sécula F; Bosch-Capblanch X; Van den Boom M; Migliori GB; Mdivani N; Yassin MA
    Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Gradmann C; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e035272. PubMed ID: 32554739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Governance of tuberculosis control programme in Nigeria.
    Ogbuabor DC; Onwujekwe OE
    Infect Dis Poverty; 2019 Jun; 8(1):45. PubMed ID: 31203814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Sustaining the DOTS': stakeholders' experience of a social protection intervention for TB in Nigeria.
    Ukwaja KN; Alobu I; Mustapha G; Onazi O; Oshi DC
    Int Health; 2017 Mar; 9(2):112-117. PubMed ID: 28204499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.
    Sidharta SD; Yin JD; Yoong JS; Khan MS
    BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study.
    Oga-Omenka C; Zarowsky C; Agbaje A; Kuye J; Menzies D
    PLoS One; 2019; 14(4):e0215542. PubMed ID: 31022228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of perspectives on access to tuberculosis health services in Xigaze, China.
    Haldane V; Zhang Z; Ma Q; Yin T; Zhang B; Li Y; Pan Q; Dainty KN; Rea E; Pasang P; Wei X; Hu J
    Infect Dis Poverty; 2021 Sep; 10(1):120. PubMed ID: 34544492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing gaps in adolescent tuberculosis programming and policy in Nigeria from a public health perspective.
    Aduh U; Ewa AU; Sam-Agudu NA; Urhioke O; Kusimo O; Ugwu C; Fadare OA; Anyaike C
    Int J Adolesc Med Health; 2021 Apr; 33(3):41-51. PubMed ID: 33913304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender inequity as a barrier to women's access to skilled pregnancy care in rural Nigeria: a qualitative study.
    Yaya S; Okonofua F; Ntoimo L; Udenige O; Bishwajit G
    Int Health; 2019 Nov; 11(6):551-560. PubMed ID: 31028382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
    PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care gaps in the global burden of drug-resistant tuberculosis.
    Cox V; Cox H; Pai M; Stillo J; Citro B; Brigden G
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):125-135. PubMed ID: 30808447
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.